23 Feb CEVEC
Nicole Faust, Ph.D., CEO
April 13 | 4:15pm | Dark Horse Consulting Ballroom
CEVEC – now part of Cytiva- is a leading provider of high-performance cell technology for the manufacturing of advanced bio-therapeutics from R&D to manufacturing scale. The company’s product portfolio comprises various platform technologies for gene therapy vectors, vector vaccines and complex recombinant proteins. In the viral vector space, ELEVECTA® is the technology of choice for AAV manufacturing. For RCA-free Adenoviral vectors, the CAP® Ad Technology is the perfect fit.